Laudolissin, a new sustained-action curariform drug. I. A preliminary evaluation of 201 cases.
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D003473:Neuromuscular Nondepolarizing Agents
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; D003473:Neuromuscular Nondepolarizing Agents
MUSCLE RELAXANTS/therapeutic use